Dr. Charles E Lavalle, M.D. Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 211 Saint Francis Dr, Attn: Infectious Disease Dept, Cape Girardeau, MO 63703 Phone: 573-331-3000 Fax: 573-331-3000 |
News Archive
BioCryst Pharmaceuticals, Inc., a pharmaceutical company focused on the development and commercialization of treatments for rare and infectious diseases, today announced that it has submitted a New Drug Application (NDA) filing for intravenous (i.v.) peramivir to the U.S. Food & Drug Administration (FDA). BioCryst is seeking an indication as the first i.v. neuraminidase inhibitor approved in the U.S. for the treatment of acute uncomplicated influenza in adults. Peramivir is approved in Japan and Korea for the treatment of influenza.
Gov. Peter Shumlin signed a bill on Thursday that sets Vermont on a path to creating the nation's first publicly financed health care. The law calls for something close to a single-payer system, with doctors and hospitals billing one entity, the state government, for their services.
The insurer said it expects to add more customers to its Medicare Advantage and individual plan businesses. Meanwhile, a few hospitals say they are doing simple surgeries for some uninsured patients for free to keep their problems from turning into emergencies that would be more expensive to treat, and those who developed meningitis as a result of tainted products seek compensation.
A new Harris Poll finds that the great majority of the public is satisfied with their lives, and that most people believe that their personal situation will improve over the next five years.
Green-chemistry researchers at McGill University have discovered a way to use water as a solvent in one of the reactions most widely used to synthesize chemical products and pharmaceuticals.
› Verified 4 days ago